Medigen Vaccine Biologics (ROCO:6547) 3-Year Book Growth Rate : 5.40% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics 3-Year Book Growth Rate?

Medigen Vaccine Biologics's Book Value per Share for the quarter that ended in Sep. 2024 was NT$11.74.

During the past 12 months, Medigen Vaccine Biologics's average Book Value per Share Growth Rate was -12.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was 5.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was 18.90% per year. During the past 10 years, the average Book Value per Share Growth Rate was 1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Medigen Vaccine Biologics was 38.60% per year. The lowest was -25.50% per year. And the median was -4.50% per year.

Competitive Comparison of Medigen Vaccine Biologics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Medigen Vaccine Biologics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Vaccine Biologics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's 3-Year Book Growth Rate falls into.

Medigen Vaccine Biologics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Medigen Vaccine Biologics (ROCO:6547) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Medigen Vaccine Biologics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Medigen Vaccine Biologics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Vaccine Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 16, Neihu Road, Lane 120, Floor 7, Section 1, Neihu District, Taipei, TWN, 11493

Website

https://www.medigenvac.com

Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of Covid-19 vaccines and Covid-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.

Medigen Vaccine Biologics Headlines

No Headlines